Kaspofungin
Kaspofungin (INN)[1][3] adalah obat antijamur lipopeptida dari Merck & Co., Inc..[4]
Nama sistematis (IUPAC) | |
---|---|
(10R,12S)-N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-Aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l] [1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide | |
Data klinis | |
Nama dagang | Cancidas |
AHFS/Drugs.com | monograph |
MedlinePlus | a615001 |
Data lisensi | US Daily Med:pranala |
Kat. kehamilan | B3(AU) |
Status hukum | Harus dengan resep dokter (S4) (AU) ℞-only (US) ℞ Preskripsi saja |
Rute | Intravenous |
Data farmakokinetik | |
Bioavailabilitas | 100% (intravenous use only) |
Ikatan protein | ~97% |
Metabolisme | Liver |
Waktu paruh | 9–11 hours |
Ekskresi | Kidney (41%), feces (35%) |
Pengenal | |
Nomor CAS | 162808-62-0 |
Kode ATC | J02AX04 |
PubChem | CID 16119814 |
DrugBank | DB00520 |
ChemSpider | 17277006 |
UNII | F0XDI6ZL63 |
KEGG | D07626 |
ChEBI | CHEBI:474180 |
ChEMBL | CHEMBL499808 |
Sinonim | (4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyltetradecanoyl)- 4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6→1)-peptide [1] 1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine] pneumocandin B0[2] |
Data kimia | |
Rumus | C52H88N10O15 |
|
Caspofungin adalah penghambat pertama sintesis (1→3)-β-D-glukan jamur yang disetujui oleh Badan Pengawas Obat dan Makanan Amerika Serikat.[5] Caspofungin diberikan secara intravena.[2] Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia.[6]
- ^ a b "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary names (Rec.INN): List 42" (PDF). World Health Organization. 1999. Diakses tanggal 11 November 2016.
- ^ a b Kesalahan pengutipan: Tag
<ref>
tidak sah; tidak ditemukan teks untuk ref bernamaCancidas FDA label
- ^ European Medicines Agency's list of authorised medicines for human use (C) Diarsipkan 17 October 2007 di Wayback Machine.
- ^ "Patent Covering Caspofungin". Diakses tanggal 18 March 2015.
- ^ Deresinski SC, Stevens DA (June 2003). "Caspofungin". Clinical Infectious Diseases. 36 (11): 1445–57. doi:10.1086/375080 . PMID 12766841.
- ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.